STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

The Oncology Institute and SilverSummit Healthplan Partner to Provide Oncology Care to Over 80,000 Medicaid Members in Nevada

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Very Positive)
Tags
partnership

The Oncology Institute (NASDAQ: TOI) has announced a significant partnership with SilverSummit Healthplan, becoming the exclusive oncology provider for over 80,000 Medicaid patients in Nevada, effective July 1. This expansion marks an important step in TOI's mission to provide value-based cancer care to underserved communities.

The partnership will operate through three Nevada locations in Las Vegas, Henderson, and Spring Valley, offering comprehensive cancer care services to SilverSummit Healthplan members. This collaboration aligns with TOI's track record of serving Medicaid patients and SilverSummit's commitment to providing high-quality healthcare access to its members.

Loading...
Loading translation...

Positive

  • Exclusive provider agreement covering over 80,000 Medicaid patients in Nevada
  • Strategic expansion of TOI's presence in the Las Vegas market through three locations
  • Extension of existing successful partnership with SilverSummit Healthplan

Negative

  • None.

Insights

TOI secures exclusive oncology provider status for 80,000 Nevada Medicaid patients, strengthening its value-based care model and expanding market reach.

The partnership between The Oncology Institute (TOI) and SilverSummit Healthplan represents a significant business expansion for TOI in the Nevada market. As the exclusive oncology provider for over 80,000 Medicaid patients, TOI gains a substantial new patient population in a single transaction.

This deal strengthens TOI's position in value-based oncology care - their core business model - and demonstrates their continued success in the Medicaid segment. Value-based care models typically align financial incentives with patient outcomes rather than service volume, potentially offering more predictable revenue streams.

The exclusivity component is particularly noteworthy, as it effectively creates a captive patient referral network and eliminates direct competition for this specific patient population. This arrangement should translate to increased patient volume across TOI's three Nevada facilities without requiring significant additional infrastructure investment.

TOI's expansion strategy appears focused on leveraging existing capabilities to serve new patient populations through partnerships with payers. This approach allows for scalable growth without the capital expenditures typically associated with de novo market entry. The company's ability to secure this contract also validates their service quality and competitive pricing model in the specialized oncology space.

For context, Medicaid reimbursements are typically lower than commercial insurance, but the volume and predictability of this patient population may offset lower per-patient margins. Additionally, TOI's mention of their "longstanding track record" with Medicaid patients suggests operational efficiency in managing this payer mix.

CERRITOS, Calif., June 30, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI”), one of the largest value-based oncology groups in the United States, announced today that effective July 1, it will be the exclusive oncology provider for over 80,000 Medicaid patients associated with SilverSummit Healthplan in Nevada. TOI is known for bringing state-of-the-art cancer care to the communities it serves, and their presence in the Las Vegas market will provide enhanced access to care and high-level services to the important Medicaid population here.

“We couldn’t be more excited about the opportunity to expand our partnership with SilverSummit and help create improved access and quality of cancer care to their Medicaid patient population,” commented Daniel Virnich, MD, CEO of The Oncology Institute. “We have a longstanding track record of providing outstanding care to Medicaid patients in other markets, and we look forward to broadening these efforts within the Las Vegas community.”

“At SilverSummit Healthplan, our top priority is ensuring our members receive the highest quality care, especially when facing a cancer diagnosis,” said Eric Schmacker, Plan President and CEO at SilverSummit Healthplan. “Partnering with The Oncology Institute allows us to connect our Medicaid members with compassionate, expert oncology care close to home—helping them navigate their treatment journey with confidence and support.”

Patient Impact

SilverSummit Healthplan members can now access TOI’s comprehensive cancer care at three convenient Nevada locations:

  • Las Vegas
    2911 N. Tenaya Way, Suite 210, Las Vegas, NV 89128
    Phone: 702-342-1244
    Hours: Monday – Friday: 8:30 am – 5:00 pm
  • Henderson
    2904 W. Horizon Ridge Pkwy, Suite 200, Henderson, NV 89052
    Phone: 702-471-7779
    Hours: Monday – Friday: 8:30 am – 5:00 pm
  • Spring Valley
    6450 Medical Center St., Las Vegas, NV 89148
    Phone: 702-739-9518
    Hours: Mon., Wed., & Fri.: 8:30 am – 5:00 pm; Tue. & Thu.: Closed

About The Oncology Institute

Founded in 2007, TOI is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of over 1.8 million patients including clinical trials, transfusions, and other services traditionally associated with the most advanced care delivery organizations. With over 120 employed clinicians and more than 700 teammates in over 70 clinic locations, TOI is changing oncology for the better.

For more information, visit www.theoncologyinstitute.com.

About SilverSummit Healthplan

SilverSummit Healthplan is a managed care plan that provides Medicaid and marketplace health insurance to the people of Nevada. Established in 2017, SilverSummit exists to improve the health of its members through focused, compassionate and coordinated care. SilverSummit is a Centene Corporation company. For more information, visit www.silversummithealthplan.com.

Contacts

Media

The Oncology Institute, Inc.
marketing@theoncologyinstitute.com

Investors

Solebury Strategic Communications
investors@theoncologyinstitute.com


FAQ

What is the new partnership between The Oncology Institute (TOI) and SilverSummit Healthplan?

TOI has become the exclusive oncology provider for over 80,000 Medicaid patients associated with SilverSummit Healthplan in Nevada, effective July 1.

Where are The Oncology Institute's (TOI) locations in Nevada?

TOI operates three locations in Nevada: Las Vegas (N. Tenaya Way), Henderson (W. Horizon Ridge Pkwy), and Spring Valley (Medical Center St.).

When does the TOI and SilverSummit Healthplan partnership take effect?

The partnership becomes effective on July 1, 2025.

What services will TOI provide to SilverSummit Healthplan members?

TOI will provide comprehensive cancer care services to SilverSummit's Medicaid members, offering state-of-the-art cancer care with enhanced access and high-level services.
The Oncology Institute Inc

NASDAQ:TOI

TOI Rankings

TOI Latest News

TOI Latest SEC Filings

TOI Stock Data

306.95M
89.19M
8.88%
40.72%
6.24%
Medical Care Facilities
Services-offices & Clinics of Doctors of Medicine
Link
United States
CERRITOS